1) Austin S, St-Pierre J:PGC-1 and mitochondrial metabolism - emerging concepts and relevance in aging and neurodegenerative disorders. J Cell Science 125:4963-4971, 2012
2) Chin, ER, Olson EN, Richardson JA, et al:A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 12:2499-2509, 1998
3) Handshin C, Spiegelman BM:PGC1-α activators, energy homeostasis, and metabolism. Endocr Rev 27:728-735, 2006
4) Handschin C, Kobayashi YM, Chin S, et al:PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev 21:770-783, 2007
5) Handshin C, Spiegelman BM:The role of exercise and PGC1-α in inflammation and chronic disease. Nature 454:463, 2008
6) Ji LL:Modulation of skeletal muscle antioxidant defense by exercise:Role of redox signaling. Free Radic Biol Med 44:142-152, 2008
7) Lin J, Handschin C, Spiegelman BM:Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418:797-801, 2002
8) Moylan JS, Reid MB:Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 35:411-429, 2007
9) Sandri M, Lin J, Handschin C, et al:PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc Natl Acad Sci USA 103:16260-16265, 2006
10) St-Pierre J, Drori S, Uldry M, et al:Suppression of reactive oxygen species and neuro- degeneration by the PGC-1 transcriptional co-activators. Cell 127:397-408, 2006